4-Aminopyridine in the treatment of alzheimer's disease
- 1 March 1988
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 23 (5), 485-490
- https://doi.org/10.1016/0006-3223(88)90020-0
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer TypeNew England Journal of Medicine, 1986
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Effects of 4-Aminopyridine in Elderly Patients with Alzheimer’s DiseaseNew England Journal of Medicine, 1984
- The Pharmacology of Human Information ProcessingPsychophysiology, 1983
- Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's DiseaseJournal of Neurochemistry, 1983
- The aminopyridinesGeneral Pharmacology: The Vascular System, 1982
- Effects of cholinergic stimulation on pituitary hormone releasePsychoneuroendocrinology, 1982
- Effects of 4-aminopyridine on the turnover of monoamines in the central nervous system of the ratJournal of Neural Transmission, 1979
- SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASEThe Lancet, 1976
- NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIESBrain, 1976